{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:45:56Z","timestamp":1791459956319,"version":"4.3.4"},"reference-count":61,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,14]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Children with sickle cell anemia (SCA) have poor growth and pubertal development. REACH (Realizing Effectiveness Across Continents with Hydroxyurea) is a prospective trial evaluating the feasibility, safety, and benefits of hydroxyurea at maximum tolerated dose (MTD) for children with SCA in sub-Saharan Africa. Children aged 1 to 10 years received open-label hydroxyurea with longitudinal follow-up. Height, weight, and pubertal staging were collected over 7 years of treatment. Biomarkers included insulin-like growth factor I (IGF-I), IGF-binding protein 3, luteinizing hormone, follicle-stimulating hormone, and anti-Mullerian hormone (AMH). Hydroxyurea commenced at an average (mean \u00b1 1 standard deviation [SD]) age of 5.9 \u00b1 2.4 years (range, 1.6-10.2) for girls (n = 296) and 5.4 \u00b1 2.4 years (range, 1.3-10.1) for boys (n = 310). Using natural history SCA-specific reference curves, the mean weight-for-age z score improved from 0.47 \u00b1 0.90 at enrollment to 0.69 \u00b1 1.00 on hydroxyurea treatment. Height increased from 0.26 \u00b1 0.90 to 0.42 \u00b1 1.00 on treatment, and body mass index from 0.46 \u00b1 1.00 to 0.85 \u00b1 1.20. IGF-I remained low in many participants. Puberty was delayed in 25% to 30% of children, with gradual progress on treatment. AMH was low (&amp;lt;2.5th percentile) in 4% of girls, whereas 52% of boys had low AMH at baseline and 28% at follow-up. Long-term hydroxyurea treatment at MTD is associated with beneficial effects on growth with improved weight and height, and does not negatively affect pubertal developmenty in children with SCA in sub-Saharan Africa. This study was registered at www.clinicaltrials.gov initially as NCT01966731 and is now registered as NCT06171217 for long-term follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025019511","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:55:59Z","timestamp":1775746559000},"page":"4483-4494","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Growth and puberty in African children with sickle cell anemia treated with hydroxyurea"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2398-9520","authenticated-orcid":false,"given":"Philippe","family":"Backeljauw","sequence":"first","affiliation":[{"name":"1Division of Endocrinology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"},{"name":"2Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9328-6399","authenticated-orcid":false,"given":"George","family":"Tomlinson","sequence":"additional","affiliation":[{"name":"3Insitute of Heath Policy, Management and Evaluation, University of Toronto, Toronto General Hospital Research Institute, Toronto, ON, Canada"},{"name":"4Department of Medicine, Toronto General Hospital Research Institute, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4083-0060","authenticated-orcid":false,"given":"Luke R.","family":"Smart","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH"},{"name":"5Division of Hematology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"},{"name":"6Global Health Center, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6318-0227","authenticated-orcid":false,"given":"L\u00e9on","family":"Tshilolo","sequence":"additional","affiliation":[{"name":"7Centre Hospitalier Monkole, Institut de Recherche Biom\u00e9dicale, Kinshasa, Democratic Republic of the Congo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4456-2382","authenticated-orcid":false,"given":"Thomas N.","family":"Williams","sequence":"additional","affiliation":[{"name":"8KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya"},{"name":"9Institute of Global Health Innovation, Department of Surgery and Cancer, Imperial College, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Br\u00edgida","family":"Santos","sequence":"additional","affiliation":[{"name":"10Hospital Pedi\u00e1trico David Bernardino, Luanda, Angola"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Olupot-Olupot","sequence":"additional","affiliation":[{"name":"11Mbale Clinical Research Institute, Mbale, Uganda"},{"name":"12Mbale Regional Referral and Teaching Hospital, Busitema University, Mbale, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Stuber","sequence":"additional","affiliation":[{"name":"5Division of Hematology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"},{"name":"6Global Health Center, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Lane","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH"},{"name":"5Division of Hematology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4473-5821","authenticated-orcid":false,"given":"Teresa","family":"Latham","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH"},{"name":"5Division of Hematology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"},{"name":"6Global Health Center, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9582-0594","authenticated-orcid":false,"given":"Russell E.","family":"Ware","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH"},{"name":"5Division of Hematology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"},{"name":"6Global Health Center, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"4 suppl","key":"2026071409565975000_bib1","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"issue":"8","key":"2026071409565975000_bib2","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021","volume":"10","author":"GBD 2021 Sickle Cell Disease Collaborators","year":"2023","journal-title":"Lancet Haematol"},{"issue":"10091","key":"2026071409565975000_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"2026071409565975000_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM198407053110102","article-title":"Influence of sickle hemoglobinopathies on growth and development","volume":"311","author":"Platt","year":"1984","journal-title":"N Engl J Med"},{"issue":"1","key":"2026071409565975000_bib5","first-page":"101","article-title":"Growth and growth hormone - insulin like growth factor-I (GH-IGF-I) axis in chronic anemias","volume":"88","author":"Soliman","year":"2017","journal-title":"Acta Biomed"},{"issue":"4","key":"2026071409565975000_bib6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/pbc.22137","article-title":"Growth patterns in children with sickle cell anemia during puberty","volume":"53","author":"Rhodes","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"5 pt 1","key":"2026071409565975000_bib7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1203\/pdr.0b013e318045bdca","article-title":"Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease","volume":"61","author":"Zemel","year":"2007","journal-title":"Pediatr Res"},{"issue":"2","key":"2026071409565975000_bib8","first-page":"E357","article-title":"Alterations in basal nutrient metabolism increase resting energy expenditure in sickle cell disease","volume":"274","author":"Borel","year":"1998","journal-title":"Am J Physiol"},{"issue":"1","key":"2026071409565975000_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-3476(00)90053-2","article-title":"Total and resting energy expenditure in children with sickle cell disease","volume":"136","author":"Barden","year":"2000","journal-title":"J Pediatr"},{"issue":"14","key":"2026071409565975000_bib10","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1080\/10408398.2017.1319794","article-title":"The role of nutrition in the pathophysiology and management of sickle cell disease among children: a review of literature","volume":"58","author":"Ohemeng","year":"2018","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"2","key":"2026071409565975000_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1515\/JPEM.2007.20.2.211","article-title":"Short stature in children with sickle cell anemia correlates with alterations in the IGF-I axis","volume":"20","author":"Collett-Solberg","year":"2007","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"2026071409565975000_bib12","first-page":"101","article-title":"Growth and growth hormone - insulin like growth factor -I (GH-IGF-I) axis in chronic anemias","volume":"88","author":"Soliman","year":"2017","journal-title":"Acta Biomed"},{"issue":"1","key":"2026071409565975000_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bcmd.2014.08.004","article-title":"Impaired pubertal development and testicular hormone function in males with sickle cell anemia","volume":"54","author":"Martins","year":"2015","journal-title":"Blood Cells Mol Dis"},{"issue":"1-2","key":"2026071409565975000_bib14","first-page":"65","article-title":"Anterior pituitary gland assessment in sickle cell anaemia patients with delayed menarche","volume":"28","author":"Abbiyesuku","year":"1999","journal-title":"Afr J Med Med Sci"},{"issue":"6","key":"2026071409565975000_bib15","first-page":"179","article-title":"Testosterone replacement therapy in adolescents with sickle cell disease reverses hypogonadism without promoting priapism: a case report","volume":"3","author":"Morrison","year":"2015","journal-title":"Urol Case Rep"},{"key":"2026071409565975000_bib16","doi-asserted-by":"crossref","first-page":"892184","DOI":"10.3389\/fendo.2022.892184","article-title":"Testosterone deficiency in sickle cell disease: recognition and remediation","volume":"13","author":"Musicki","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2026071409565975000_bib17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/adc.82.3.204","article-title":"Height and weight reference curves for homozygous sickle cell disease","volume":"82","author":"Thomas","year":"2000","journal-title":"Arch Dis Child"},{"issue":"20","key":"2026071409565975000_bib18","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"issue":"9778","key":"2026071409565975000_bib19","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","article-title":"Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomized, controlled trial (BABY HUG)","volume":"377","author":"Wang","year":"2011","journal-title":"Lancet"},{"issue":"26","key":"2026071409565975000_bib20","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1182\/blood-2009-04-146852","article-title":"How I use hydroxyurea to treat young patients with sickle cell anemia","volume":"115","author":"Ware","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2026071409565975000_bib21","first-page":"1061","article-title":"The modern use of hydroxyurea for children with sickle cell anemia","volume":"110","author":"Quinn","year":"2025","journal-title":"Haematologica"},{"issue":"24","key":"2026071409565975000_bib22","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood-2017-06-788935","article-title":"Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia","volume":"130","author":"Opoka","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2026071409565975000_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1056\/NEJMoa1813598","article-title":"Hydroxyurea for children with sickle cell anemia in sub-Saharan Africa","volume":"380","author":"Tshilolo","year":"2019","journal-title":"N Engl J Med"},{"issue":"26","key":"2026071409565975000_bib24","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1056\/NEJMoa2000146","article-title":"Hydroxyurea dose escalation for sickle cell anemia in sub-Saharan Africa","volume":"382","author":"John","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"2026071409565975000_bib25","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1016\/S2352-3026(24)00078-4","article-title":"Hydroxyurea dose optimization for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1\/2 trial","volume":"11","author":"Aygun","year":"2024","journal-title":"Lancet Haematol"},{"issue":"3","key":"2026071409565975000_bib26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1542\/peds.2014-0917","article-title":"Hydroxyurea and growth in young children with sickle cell disease","volume":"134","author":"Rana","year":"2014","journal-title":"Pediatrics"},{"issue":"9","key":"2026071409565975000_bib27","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/humrep\/dey240","article-title":"Spermatogonial quantity in human prepubertal testicular tissue collected for fertility preservation prior to potentially sterilizing therapy","volume":"33","author":"Stukenborg","year":"2018","journal-title":"Hum Reprod"},{"issue":"5","key":"2026071409565975000_bib28","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/bjh.16976","article-title":"Hydroxycarbamide exposure ovarian reserve in women with sickle cell disease in the Multicenter Study of Hydroxycarbamide","volume":"191","author":"Pecker","year":"2020","journal-title":"Br J Haematol"},{"issue":"1","key":"2026071409565975000_bib29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/pbc.25705","article-title":"Hydroxyurea therapy for children with sickle cell anemia in sub-Saharan Africa: rationale and design of the REACH trial","volume":"63","author":"McGann","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"2026071409565975000_bib30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ajh.25034","article-title":"Realizing Effectiveness Across Continents with Hydroxyurea: enrollment and baseline characteristics of the multicenter REACH study in sub-Saharan Africa","volume":"93","author":"McGann","year":"2018","journal-title":"Am J Hematol"},{"key":"2026071409565975000_bib31","author":"Tanner","year":"1962","edition":"2nd ed"},{"issue":"5","key":"2026071409565975000_bib32","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1210\/jc.2013-3059","article-title":"Reference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations","volume":"99","author":"Bidlingmaier","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026071409565975000_bib33","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1210\/jc.2013-3060","article-title":"Age- and sex-specific reference intervals across life span for insulin-like growth factor binding protein 3 (IGFBP-3) and the IGF-I to IGFBP-3 ratio measured by new automated chemiluminescence assays","volume":"99","author":"Friedrich","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026071409565975000_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.clinbiochem.2022.06.005","article-title":"Anti-mullerian hormone (AMH) reference values in the CALIPER cohort of healthy community children and adolescents","volume":"108","author":"Ronn","year":"2022","journal-title":"Clin Biochem"},{"issue":"3","key":"2026071409565975000_bib35","doi-asserted-by":"crossref","first-page":"100031","DOI":"10.1016\/j.bglo.2025.100031","article-title":"Growth in Kenyan children with sickle cell anemia: development of disease-specific growth curves","volume":"1","author":"Tomlinson","year":"2025","journal-title":"Blood Glob Hematol"},{"key":"2026071409565975000_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1651-2227.2006.tb02378.x","article-title":"WHO Child growth standards based on length\/height, weight and age","volume":"450","author":"WHO Multicentre Growth Reference Study Group","year":"2006","journal-title":"Acta Paediatr Suppl"},{"issue":"9","key":"2026071409565975000_bib37","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2471\/BLT.07.043497","article-title":"Development of a WHO growth reference for school-aged children and adolescents","volume":"85","author":"de Onis","year":"2007","journal-title":"Bull World Health Organ"},{"issue":"4","key":"2026071409565975000_bib38","doi-asserted-by":"crossref","first-page":"e195881","DOI":"10.1001\/jamapediatrics.2019.5881","article-title":"Worldwide secular trends in age at pubertal onset among girls assessed by breast development: a systematic review and meta-analysis","volume":"174","author":"Eckert-Lind","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"9","key":"2026071409565975000_bib39","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archpedi.155.9.1022","article-title":"Secondary sexual characteristics in boys: estimates from the National Health and Nutrition Examination Survey III, 1988-1994","volume":"155","author":"Herman-Giddens","year":"2001","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"5","key":"2026071409565975000_bib40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/adc.85.5.375","article-title":"Sickle cell disease and age at menarche in Jamaican girls: observations from a cohort study","volume":"85","author":"Serjeant","year":"2001","journal-title":"Arch Dis Child"},{"issue":"8","key":"2026071409565975000_bib41","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1515\/cclm-2021-0050","article-title":"Pediatric reference intervals for endocrine markers and fertility hormones in healthy children and adolescents on the Siemens Healthineers Atellica immunoassay system","volume":"59","author":"Bohn","year":"2021","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"2026071409565975000_bib42","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/aogs.13574","article-title":"Biomarkers of ovarian reserve in childhood and adolescence: a systematic review","volume":"98","author":"Bhide","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2026071409565975000_bib43","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13633-016-0038-2","article-title":"Anti-Mullerian hormone as a marker of steroid and gonadotropin action in the testis of children and adolescents with disorders of the gonadal axis","volume":"2016","author":"Edelsztein","year":"2016","journal-title":"Int J Pediatr Endocrinol"},{"issue":"2","key":"2026071409565975000_bib44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1067\/mpd.2002.121383","article-title":"Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS Study","volume":"140","author":"Wang","year":"2002","journal-title":"J Pediatr"},{"issue":"11","key":"2026071409565975000_bib45","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0026-0495(97)90224-9","article-title":"Growth hormone secretion and circulating insulin-like growth factor-I (IGF-I) and IGF binding protein-3 concentrations in children with sickle cell disease","volume":"46","author":"Soliman","year":"1997","journal-title":"Metabolism"},{"issue":"5","key":"2026071409565975000_bib46","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/tropej\/41.5.285","article-title":"Circulating growth hormone (GH), insulin-like growth factor-I (IGF-I) and free thyroxine, GH response to clonidine provocation and CT scanning of the hypothalamic-pituitary area in children with sickle cell disease","volume":"41","author":"Soliman","year":"1995","journal-title":"J Trop Pediatr"},{"issue":"3","key":"2026071409565975000_bib47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1179\/146532808X335624","article-title":"Growth and nutritional status of children with homozygous sickle cell disease","volume":"28","author":"Al-Saqladi","year":"2008","journal-title":"Ann Trop Paediatr"},{"issue":"5","key":"2026071409565975000_bib48","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/adc.71.5.404","article-title":"Delayed adolescent growth in homozygous sickle cell disease","volume":"71","author":"Singhal","year":"1994","journal-title":"Arch Dis Child"},{"issue":"8","key":"2026071409565975000_bib49","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/MPH.0000000000001477","article-title":"Effect of sickle cell anemia therapies on the natural history of growth and puberty patterns","volume":"41","author":"Nagalapuram","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"issue":"28","key":"2026071409565975000_bib50","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1097\/MD.0000000000000215","article-title":"From infancy to adolescence: fifteen years of continuous treatment with hydroxyurea in sickle cell anemia","volume":"93","author":"Hankins","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"2026071409565975000_bib51","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12887-019-1423-9","article-title":"Endocrine and metabolic complications in children and adolescents with sickle cell disease: an Italian cohort study","volume":"19","author":"Mandese","year":"2019","journal-title":"BMC Pediatr"},{"issue":"2","key":"2026071409565975000_bib52","doi-asserted-by":"crossref","first-page":"e0213024","DOI":"10.1371\/journal.pone.0213024","article-title":"Ovarian reserve in women with sickle cell disease","volume":"14","author":"Kopeika","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"2026071409565975000_bib53","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bcmd.2015.03.012","article-title":"The effects of hydroxyurea and bone marrow transplant on anti-Mullerian hormone (AMH) levels in females with sickle cell anemia","volume":"55","author":"Elchuri","year":"2015","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"2026071409565975000_bib54","first-page":"683","article-title":"Functional ovarian reserve in women with sickle cell disease: a systematic review","volume":"28","author":"Silva","year":"2024","journal-title":"JBRA Assist Reprod"},{"issue":"6","key":"2026071409565975000_bib55","doi-asserted-by":"crossref","first-page":"e0304241","DOI":"10.1371\/journal.pone.0304241","article-title":"Effects of hydroxyurea on fertility in male and female sickle cell disease patients. A systemic review and meta-analysis","volume":"19","author":"Sewaralthahab","year":"2024","journal-title":"PLoS One"},{"issue":"2","key":"2026071409565975000_bib56","doi-asserted-by":"crossref","first-page":"e0213024","DOI":"10.1371\/journal.pone.0213024","article-title":"Ovarian reserve in women with sickle cell disease","volume":"14","author":"Kopeika","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"2026071409565975000_bib57","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/bjh.16976","article-title":"Hydroxycarbamide exposure and ovarian reserve in women sickle cell disease in the Multicenter Study of Hydroxycarbamide","volume":"191","author":"Pecker","year":"2020","journal-title":"Br J Haematol"},{"issue":"6","key":"2026071409565975000_bib58","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/humrep\/dez043","article-title":"Testicular tissue cryopreservation: 8 years of experience from a coordinated network of academic centers","volume":"34","author":"Valli-Pulaski","year":"2019","journal-title":"Hum Reprod"},{"issue":"6","key":"2026071409565975000_bib59","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1182\/blood.2020008146","article-title":"Hydroxyurea does not affect the spermatogonial pool in prepubertal patients with sickle cell disease","volume":"137","author":"Gille","year":"2021","journal-title":"Blood"},{"issue":"3","key":"2026071409565975000_bib60","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/em.22536","article-title":"Lack of hydroxyurea-associated mutagenesis in pediatric sickle cell disease patients","volume":"64","author":"Torous","year":"2023","journal-title":"Environ Mol Mutagen"},{"issue":"6","key":"2026071409565975000_bib61","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1182\/blood.2020006270","article-title":"Effect of hydroxyurea exposure before puberty on sperm parameters in males with sickle cell disease","volume":"137","author":"Joseph","year":"2021","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/13\/4483\/2530114\/blooda_adv-2025-019511-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/13\/4483\/2530114\/blooda_adv-2025-019511-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:57:10Z","timestamp":1784037430000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/13\/4483\/567645\/Growth-and-puberty-in-African-children-with-sickle"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":61,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,7,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025019511","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7,14]]},"published":{"date-parts":[[2026,6,25]]}}}